Lv2
170 积分 2025-11-21 加入
AGA Clinical Practice Update on Endoscopic Scoring Systems in Inflammatory Bowel Disease: Commentary
6天前
已完结
S1423 RIPK2 Scaffolding Inhibitors are a Novel Approach to Block RIPK2 Signaling, a Hallmark of Inflammatory Bowel Disease
7天前
已完结
Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease
7天前
已完结
Treatment of uveitis in Blau syndrome: A systematic review and meta-analysis
1个月前
已完结
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
2个月前
已完结
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
2个月前
已完结
The role of JAK/STAT signaling pathway and its inhibitors in diseases
2个月前
已完结
RIPK2 inhibitors for disease therapy: Current status and perspectives
3个月前
已完结
Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease
3个月前
已完结
皖公网安备34019202002308
